Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125895 | 0.77 | — | — | |
| SCHEMBL10574849 | 0.77 | ALDH1A1 (0.38) | ALDH1A1LMNATSHR | |
| SCHEMBL1572578 | 0.77 | LMNA (0.47) | ALDH1A1LMNATSHR | |
| SCHEMBL3900511 | 0.74 | ALDH1A1 (0.36) | ALDH1A1LMNA | |
| SCHEMBL19467 | 0.72 | — | — | |
| SCHEMBL6179035 | 0.72 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL1263276 | 0.72 | — | — | |
| SCHEMBL8467687 | 0.72 | — | — | |
| SCHEMBL1263275 | 0.72 | — | — | |
| SCHEMBL16786171 | 0.72 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613414-A | Non-azolanet Process for the preparation of tam | 上海皓元医药股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-12059467-B2 | Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same | ANHUI UNIVERSITY (CN) | 2024-08-13 | — | — | US | claimed |
| US-20240108728-A1 | IMPROVED LOW-TOXICITY AND HIGH-EFFICIENCY ORTHOESTER MIXTURE PHARMACEUTICAL ADJUVANT, PREPARATION METHOD THEREOF, AND TOPICAL SUSTAINED RELEASE DRUG DELIVERY FORMULATION INCLUDING SAME | ANHUI UNIVERSITY (CN) | 2024-04-04 | — | — | US | claimed |
| WO-2023221320-A1 | IMPROVED LOW-TOXICITY AND HIGHLY EFFICIENT PHARMACEUTICAL EXCIPIENT OF ORTHOESTER MIXTURE, METHOD FOR PREPARING SAME, AND LOCAL SUSTAINED-RELEASE PREPARATION COMPRISING SAME | 安徽大学 | 2023-11-23 | — | — | WO | claimed |
| CN-114848585-B | Improved low-toxicity high-efficiency orthoester miscible medicinal adjuvant, preparation method and local sustained-release drug delivery preparation containing adjuvant | 安徽大学 | 2023-03-28 | — | — | CN | claimed |
| CN-114848585-A | Improved low-toxicity high-efficiency orthoester miscible medicine pharmaceutic adjuvant, preparation method and local sustained-release administration preparation containing adjuvant | 安徽大学 | 2022-08-05 | — | — | CN | claimed |
| CN-111116423-A | Process method for preparing tert-butyl isocyano | 苏州百灵威超精细材料有限公司 | 2020-05-08 | — | — | CN | claimed |
| US-5932747-A | Method for preparing 1,3-dioxane compounds | HUELS AKTIENGESELLSCHAFT (DE) | 1999-08-03 | — | — | US | claimed |
| US-5760275-A | CATALYZING WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF GROUP 8 METAL COMPOUND | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1998-06-02 | — | — | US | claimed |
| CN-121154837-B | Crosslinked nano prodrug, nano self-assembled hydrogel precursor tablet prepared from crosslinked nano prodrug and application of nano self-assembled hydrogel precursor tablet | ANHUI UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-119613414-A | Non-azolanet Process for the preparation of tam | 上海皓元医药股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-12059467-B2 | Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same | ANHUI UNIVERSITY (CN) | 2024-08-13 | — | — | US | disclosed |
| US-20240108728-A1 | IMPROVED LOW-TOXICITY AND HIGH-EFFICIENCY ORTHOESTER MIXTURE PHARMACEUTICAL ADJUVANT, PREPARATION METHOD THEREOF, AND TOPICAL SUSTAINED RELEASE DRUG DELIVERY FORMULATION INCLUDING SAME | ANHUI UNIVERSITY (CN) | 2024-04-04 | — | — | US | disclosed |
| WO-2023221320-A1 | IMPROVED LOW-TOXICITY AND HIGHLY EFFICIENT PHARMACEUTICAL EXCIPIENT OF ORTHOESTER MIXTURE, METHOD FOR PREPARING SAME, AND LOCAL SUSTAINED-RELEASE PREPARATION COMPRISING SAME | 安徽大学 | 2023-11-23 | — | — | WO | disclosed |
| US-4001230-A | ANTIBACTERIAL, ANTIPROTAZOAL | ELI LILLY AND COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3988356-A | Novel haptenes and antigens | ROUSSEL-UCLAF (FR) | 1976-10-26 | — | — | US | disclosed |
| US-3981717-A | ANILINO COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3980794-A | Method for promoting growth of poultry with 3-(5-nitro-2-imidazolyl)pyrazoles | ELI LILLY AND COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3975413-A | Novel haptenes and antigens | PIERDET ANDRE | 1976-08-17 | — | — | US | disclosed |
| US-3947467-A | ANTIBACTERIAL, ANTIPROTOZOAL, ANTIFUNGAL | ELI LILLY AND COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108728-A1 | IMPROVED LOW-TOXICITY AND HIGH-EFFICIENCY ORTHOESTER MIXTURE PHARMACEUTICAL ADJUVANT, PREPARATION METHOD THEREOF, AND TOPICAL SUSTAINED RELEASE DRUG DELIVERY FORMULATION INCLUDING SAME | TLR7, PON1, MYD88 | THRB 3938/4885ALDH1A1 1589/4885LMNA 4613/4885 |
| US-12059467-B2 | Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same | TLR7, PON1, MYD88 | THRB 3881/4885ALDH1A1 1529/4885LMNA 4595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.